Investing.com - Financial Markets Worldwide
Open in App

Genolution Inc (225220)

KOSDAQ
Currency in KRW
1,414
-6(-0.42%)
Closed·

225220 Income Statement

Period Ending:
2022
31/12
2023
31/12
2024
31/12
2025
31/12
Total Revenues
38,084.579,761.37,135.749,404.35
Total Revenues Growth
--74.37%-26.9%+31.79%
Cost Of Revenues
12,177.095,303.944,835.815,962.29
Gross Profit
25,907.484,457.362,299.933,442.06
Gross Profit Growth
--82.8%-48.4%+49.66%
Gross Profit Margin %
68.03%45.66%32.23%36.6%
Other Operating Expenses, Total
11,170.7811,548.7411,463.912,083.98
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
-+3.38%-0.73%+5.41%
1,515.923,081.41,671.58471.61
8,783.737,075.528,073.799,481.11
-18.12330.46252.32272.93
Operating Income
14,736.7-7,091.38-9,163.97-8,641.92
Operating Income Growth
--148.12%-29.23%+5.7%
EBIT Margin %
38.69%-72.65%-128.42%-91.89%
Net Interest Expenses
353.911,835.351,390.4318.29
Net Interest Expenses Growth
-+418.59%-24.24%-77.11%
Interest Expense, Total
-311.61--418.09-875.62
Interest And Investment Income
665.521,835.351,808.491,193.91
Other Non Operating Expenses, Total
2,126.23778.864,137.06-300.41
EBT, Excl. Unusual Items
17,216.84-4,477.18-3,636.51-8,624.04
Gain (Loss) On Sale Of Assets
218.54-2,576.59--25.56
Other Unusual Items, Total
262.4-141.55-17-2,143.37
EBT, Incl. Unusual Items
17,238.76-6,653.18-6,771.44-12,585.69
EBT, Incl. Unusual Items Growth
--138.59%-1.78%-85.86%
EBT, Incl. Unusual Items Margin
45.26%-68.16%-94.89%-133.83%
Income Tax Expense
2,636.89-1,102.81437.363.9
Net Income to Company
14,601.87-5,550.37-7,208.79-12,589.59
Minority Interest
-38.75383.22947.03
Net Income
14,601.87-5,511.62-6,825.57-11,642.56
Net Income Growth
--137.75%-23.84%-70.57%
Net Income Margin %
38.34%-56.46%-95.65%-123.8%
Preferred Dividend and Other Adjustments
----
Net Income to Common Excl. Extra Items
14,601.87-5,511.62-6,825.57-11,642.56
Basic EPS - Continuing Operations
800.93-300.43-378-644.48
Basic EPS - Continuing Operations Growth
--137.51%-25.82%-70.5%
Diluted EPS - Continuing Operations
768.91-300.43-378-644.48
Diluted EPS - Continuing Operations Growth
--139.07%-25.82%-70.5%
Basic Weighted Average Shares Outstanding
18.2318.3518.0618.07
Diluted Weighted Average Shares Outstanding
18.8818.3518.0618.07
Dividend Per Share
----
Dividend Per Share Growth
----
EBITDA
16,064.65-5,513.23-7,123.18-6,278.77
EBITDA Growth
--134.32%-29.2%+11.85%
EBITDA Margin %
42.18%-56.48%-99.82%-66.76%
EBIT
14,736.7-7,091.38-9,163.97-8,641.92
* In Millions of KRW (except for per share items)

FAQ

What was Genolution’s revenue at year end?

At the end of the last reported fiscal year, Genolution (225220) recorded total revenue of 9,404 million KRW.

How much revenue did Genolution report in the most recent quarter?

In its most recent quarterly earnings report, Genolution posted revenue of 3,092 million KRW.

What was Genolution’s net income for the year?

For the full year, Genolution reported net income of -11,643 million KRW.

How much net income did Genolution post in the last quarter?

In the most recent quarter, Genolution (225220) posted net income of 775 million KRW.

What was Genolution’s gross profit for the year?

Gross profit for the year was reported at 3,442 million KRW.

How much gross profit did Genolution generate last quarter?

Genolution recorded gross profit of 1,046 million KRW in its latest quarterly report.

What was Genolution’s annual operating income?

For the full year, Genolution (225220) reported operating income of -8,642 million KRW.

What was Genolution’s operating income last quarter?

Quarterly operating income was -1,594 million KRW.

What was Genolution’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -1,341 million KRW.

What was the quarter-over-quarter change in EBITDA for Genolution?

EBITDA changed by -19% million KRW compared to the last quarter.

What is Genolution’s most recent gross profit margin?

The latest reported gross profit margin for Genolution (225220) is 34% million KRW.

What is Genolution’s most recent net income margin?

Net income margin based on recent financials is 25% million KRW.

What is Genolution’s most recent EBIT margin?

Genolution reported an EBIT margin of -52% million KRW based on current figures.

How did Genolution’s revenue change compared to the previous quarter?

Revenue changed by 24% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Genolution?

In the latest quarter, gross profit changed by 17% million KRW from the previous quarter.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.